GAMMA Investing LLC increased its stake in Stryker Corporation by 16.4%, bringing its total investment to $2.08 million.

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Stryker (SYK – Research Report), with a price target of $450.00. The companys ...

Stryker has appointed Mike Carlin to lead its digital and robotics business. Spencer Stiles, Stryker’s group president of ...

Stryker has received 510(k) clearance from the FDA for its Incompass Total Ankle System, a next-generation implant targeting ...

Suryakumar Yadav surprised fans with a health update on Wednesday, June 25. From a Munich hospital bed, SYK shared an ...

This was the stock's fourth consecutive day of gains.

Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over the ...

Stryker (NYSE:SYK) announced today that it received FDA 510(k) clearance for its Incompass total ankle system.

New York-based Formation Bio, an AI-native pharma company focused on accelerating drug development, revealed that its ...

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi ...

This has positioned BSX as the second-largest player globally, largely due to the rapid adoption of pulsed field ablation ...